Diprivan

Known as: Astra Brand of Propofol, Disoprivan, AstraZeneca Brand of Propofol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Propofol (Disoprivan, AstraZeneca AG, Zug, Switzerland) has long been considered to be nonanalgesic. However… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter, activates a persistent low amplitude tonic current in… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2001
2001
BACKGROUND Pain on injection is a major disadvantage of propofol, experienced by the vast majority of patients. Since the… (More)
Is this relevant?
2000
2000
UNLABELLED Propofol (Diprivan(TM); AstraZeneca, Wilmington, DE) is a commonly used drug for the induction of general anesthesia… (More)
Is this relevant?
1998
1998
We separately studied the antioxidant properties of propofol (PPF), Diprivan (the commercial form of PPF) and intralipid (IL… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Fourteen patients who had had a life-threatening reaction within a few minutes after receiving propofol (Diprivan) were… (More)
Is this relevant?
1992
1992
We describe the use of propofol (Diprivan) to provide patient comfort during the initial stages of awake craniotomies. 
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The pharmacokinetics of propofol (2,6 diisopropylphenol) were compared in 12 patients aged 65-80 yr and 12 patients aged 18-35 yr… (More)
Is this relevant?
1985
1985
Twenty patients scheduled for elective coronary surgery received either propofol ('Diprivan') 1.5 mg/kg in emulsion or… (More)
Is this relevant?
1983
1983
In order to avoid Cremophor-related reactions and reduce the incidence of pain on injection, diisopropylphenol (ICI 35,868… (More)
Is this relevant?